Interdisziplinäre Arbeitsgruppe Nierenzellkarzinom – IAG-N: Studien

AIO-assoziierte Studie für weitere Zentren offen
www.clinicaltrials.gov zur Studie

AIO-NZK-0116/ass: A randomized phase II study with NIVOlumab or continuation of therapy as an early SWITCH approach in patients with advanced or metastatic renal cell carcinoma (RCC) and disease control after 3 months of treatment with a tyrosine kinase inhibitor (NIVOSWITCH)
  ---in Rekrutierung---


AIO-assoziierte Studie für weitere Zentren offen
www.clinicaltrials.gov zur Studie

AIO-NZK-0115: A phase III study testing the role of proactive coaching on patient reported outcome in metastatic renal cell carcinoma treated with sunitinib [PREPARE]
Artikel zur PREPARE-Studie im FORUM Juni 2017
  ---in Rekrutierung---


AIO-assoziierte Studie für weitere Zentren offen
www.clinicaltrials.gov zur Studie

AIO-NZK-0117/ass: A Phase 2, Randomized, Open-Label Study of Nivolumab Combined with Ipilimumab Versus Sunitinib Monotherapy in Subjects with Previously Untreated and Advanced (unresectable or  metastatic) non-clear Cell Renal Cell Carcinoma - SUNNIFORECAST
  ---in Vorbereitung---